A Gilbert doctor and researcher is central to a new international society that has drawn together the top minds in medicine for stem cell and genomic research. The aim of the group: Bring results more quickly to patients and save lives.
Dr. Nabil Dib, whose research facility is housed in Mercy Gilbert Medical Center, is the founder of the new International Society for Cardiovascular Translational Research.
This weekend, the group will meet in San Diego for its inaugural forum that will focus on bringing together top doctors from the U.S. and other nations who are researching the use of adult stem cells to help heart attack patients, and the use of genetic code to diagnose and prevent future cardiac patients.
"This brings together the top minds in stem cell and genomic research," Dib said. "It's a big deal for medicine. Patients can also learn a lot."
The symposium is held by Catholic Healthcare West in conjunction with the University of California San Diego's School of Medicine. The forum begins Saturday at the Hotel del Coronado in San Diego, and is open to the public.
"The forum will provide up-to-date information on adult stem therapy for cardiovascular disease, the future of personalized medicine and genomics in early diagnosis," said David G. Covert, president and CEO of the CHW East Valley Service Area and Chandler Regional Medical Center.
The goal:"The prevention and treatment of cardiovascular disease," Covert said.
Dib recently earned approval for the second leg of his ongoing research that looks at using adult stem cells from thigh muscles to regenerate dead heart tissue.
Using a catheter, Dib injects the healthy stem cells from an adult's thigh into the heart, where the cells take on characteristics of heart muscles and bring dead heart tissue that has been damaged from a heart attack back to life - preventing death or suffering that often results from the damaged heart, he said.
Dib said he expects to take on about 30 local patients when the second phase of the study moves forward this year. His study has been approved for as many as 160 patients around the world, as other doctors work with him on the research.
Dib said he began the International Society for Cardiovascular Translational Research late last year with the goal of bringing together researchers to share information, and bring their research quickly to patients. Often, it takes too long to bring good research into hospitals, Dib said.
Patients at the Gilbert hospital at the Loop 202 Santan Freeway and Val Vista Drive, will be able to be a part of the research during their care, he said.